Health Care

Filter By:



Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

Blank Section (Placeholder)

Rescuing ObamaCare

by John F. Coganvia Hoover Digest
Wednesday, January 27, 2016

The best cure? High-deductible plans and health savings accounts.

Analysis and Commentary

Three Great Comments On My FDA Post

by David R. Hendersonvia EconLog
Tuesday, January 5, 2016

Three people, Jim Glass, Dan Klein, and db, made important comments on my FDA post yesterday.

Analysis and Commentary

The Problem With FDA Restrictions On Drugs

by David R. Hendersonvia EconLog
Monday, January 4, 2016

Or, actually, one of many problems. When asked specifically how his wife's illness had changed his work at the F.D.A., Dr. Pazdur said he was intent on making decisions more quickly.


Richard Epstein On The John Batchelor Show

interview with Richard A. Epsteinvia John Batchelor Show
Friday, January 1, 2016

Hoover Institution fellow Richard Epstein discusses the future of Obamacare/the Affordable Care Act.

Analysis and Commentary

Can The Creation Of 'Human GMOs' Cure Genetic Diseases?

by Henry I. Millervia Forbes
Wednesday, December 16, 2015

“Human gene therapy” has been one of the most ambitious goals of biotechnology since the advent of molecular techniques for genetic modification in the 1970’s. There are two distinct approaches to it, and they present different kinds of benefits, risks and controversies.

Analysis and Commentary

To Modulate Drug Prices, We Need Less — Not More — Government Involvement

by Henry I. Miller, John Cohrssenvia National Review
Friday, December 11, 2015

In order to control escalating U.S. drug prices that seem to be disconnected from research, development, and manufacturing costs, an array of politicians, policy experts, and pundits have proposed a spectrum of government interventions of varying intrusiveness.


The Health Of Obamacare

by Daniel P. Kesslervia Wall Street Journal
Friday, December 11, 2015

The best scholarly analyses of the Affordable Care Act suggest that it’s neither the triumph trumpeted by its proponents nor the disaster suggested by its critics.

In the News

Health And Law

quoting Daniel P. Kesslervia Stanford Lawyer
Wednesday, November 11, 2015

When Former New York City Mayor Michael Bloomberg took a stand on sugary drinks, banning large sizes to encourage moderation, his efforts were met with some applause—but also with jeers of derision, one New York Post headline dubbing him the “Soda Jerk.”

In the News

Improving Health And Health Care: An Agenda For Reform

with Lanhee J. Chenvia American Enterprise Institute
Wednesday, December 9, 2015

The debate over, and eventual enactment of, the Affordable Care Act (ACA) brought to the surface of American politics a long-standing divide over the proper orientation of health care policy. On one side are those who tend to promote more federal control and government regulation over insurance markets and the organizations delivering services to patients.

In the News

American Enterprise Institute: Improving Health and Health Care, An Agenda for Reform

with Lanhee J. Chenvia American Enterprise Institute
Wednesday, December 9, 2015

Despite, and in a sense because of, the enactment of the Affordable Care Act (ACA) in 2010, US health care is still badly in need of reform and revitalization. Instead of more federal regulation and subsidies, what US health care needs is adoption of market principles, starting with broad empowerment of the patient-consumer.


Health Care Policy Working Group

The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.